MENU
+Compare
BLFS
Stock ticker: NASDAQ
AS OF
Feb 21 closing price
Price
$26.67
Change
-$0.84 (-3.05%)
Capitalization
810.87M

BLFS BioLife Solutions Forecast, Technical & Fundamental Analysis

a manufacturer of proprietary and generic bio preservation media products for cells, tissues and organs

BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for BLFS with price predictions
Feb 18, 2025

BLFS in upward trend: price rose above 50-day moving average on February 13, 2025

BLFS moved above its 50-day moving average on February 13, 2025 date and that indicates a change from a downward trend to an upward trend. In of 34 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on February 14, 2025. You may want to consider a long position or call options on BLFS as a result. In of 96 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for BLFS just turned positive on February 18, 2025. Looking at past instances where BLFS's MACD turned positive, the stock continued to rise in of 41 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BLFS advanced for three days, in of 327 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for BLFS crossed bearishly below the 50-day moving average on February 12, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BLFS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. BLFS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. BLFS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 89, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.402) is normal, around the industry mean (23.499). P/E Ratio (238.095) is within average values for comparable stocks, (83.627). Projected Growth (PEG Ratio) (15.094) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (5.461) is also within normal values, averaging (41.339).

View a ticker or compare two or three
BLFS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

BLFS is expected to report earnings to rise 106.25% to -8 cents per share on March 13

BioLife Solutions BLFS Stock Earnings Reports
Q4'24
Est.
$-0.08
Q3'24
Beat
by $0.04
Q2'24
Missed
by $0.36
Q1'24
Beat
by $0.13
Q4'23
Beat
by $0.04
The last earnings report on November 12 showed earnings per share of -3 cents, beating the estimate of -7 cents. With 259.87K shares outstanding, the current market capitalization sits at 810.87M.
A.I. Advisor
published General Information

General Information

a manufacturer of proprietary and generic bio preservation media products for cells, tissues and organs

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
3303 Monte Villa Parkway
Phone
+1 425 402-1400
Employees
414
Web
https://www.biolifesolutions.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPY611.491.79
+0.29%
SPDR® S&P 500® ETF Trust
AAPL244.47-0.13
-0.05%
Apple
GME26.97-0.03
-0.11%
GameStop Corp
BTC.X95539.550000-233.835940
-0.24%
Bitcoin cryptocurrency
TSLA354.11-1.73
-0.49%
Tesla

BLFS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, BLFS has been loosely correlated with AZTA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if BLFS jumps, then AZTA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLFS
1D Price
Change %
BLFS100%
+1.98%
AZTA - BLFS
52%
Loosely correlated
-2.22%
RGEN - BLFS
48%
Loosely correlated
-1.18%
VCYT - BLFS
44%
Loosely correlated
-1.68%
GKOS - BLFS
41%
Loosely correlated
-0.16%
RDNT - BLFS
40%
Loosely correlated
+0.21%
More